Woodward Total Cost of Revenue increased by 10.0% to $774.66M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.4%, from $643.53M to $774.66M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 11.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $422.46M | $436.43M | $419.15M | $453.43M | $480.40M | $504.51M | $492.66M | $559.15M | $596.25M | $587.51M | $582.38M | $600.95M | $617.70M | $646.73M | $583.09M | $643.53M | $666.29M | $717.86M | $704.29M | $774.66M |
| QoQ Change | — | +3.3% | -4.0% | +8.2% | +5.9% | +5.0% | -2.3% | +13.5% | +6.6% | -1.5% | -0.9% | +3.2% | +2.8% | +4.7% | -9.8% | +10.4% | +3.5% | +7.7% | -1.9% | +10.0% |
| YoY Change | — | — | — | — | +13.7% | +15.6% | +17.5% | +23.3% | +24.1% | +16.5% | +18.2% | +7.5% | +3.6% | +10.1% | +0.1% | +7.1% | +7.9% | +11.0% | +20.8% | +20.4% |
| Segment | Q1 '26 |
|---|---|
| Aerospace | $506.06M |
| Industrial | $268.27M |
| Total | $774.66M |